von der Emde, Leon
Mallwitz, Merten
Vaisband, Marc
Hasenauer, Jan
Saßmannshausen, Marlene
Terheyden, Jan Henrik
Agostini, H.
Altay, L.
Atia, R.
Bandello, F.
Basile, P. G.
Batuca, J.
Behning, C.
Belmouhand, M.
Berger, M.
Binns, A.
Boon, C. J. F.
Böttger, M.
Bouchet, C.
Brazier, J. E.
Butt, T.
Carapezzi, C.
Carlton, J.
Carneiro, A.
Charil, A.
Coimbra, R.
Cozzi, M.
Crabb, D. P.
Cunha-Vaz, J.
Dahlke, C.
de Sisternes, L.
Dunbar, H.
Finger, R. P.
Fletcher, E.
Floyd, H.
Francisco, C.
Gutfleisch, M.
Hinz, S.
Hogg, R.
Holz, F. G.
Hoyng, C. B.
Kilani, A.
Krätzschmar, J.
Kühlewein, L.
Larsen, M.
Leal, S.
Lechanteur, Y. T. E.
Luhmann, U. F. O.
Lüning, A.
Marques, I.
Martinho, C.
Montesano, G.
Mulyukov, Z.
Paques, M.
Parodi, B.
Parravano, M.
Penas, S.
Peters, T.
Peto, T.
Pfau, M.
Poor, S.
Priglinger, S.
Rowen, D.
Rubin, G. S.
Sahel, J.
Sánchez, C.
Sander, O.
Saßmannshausen, M.
Schmid, M.
Schmitz-Valckenberg, S.
Siedlecki, J.
Silva, R.
Skelly, A.
Souied, E.
Staurenghi, G.
Stöhr, L.
Taylor, D. J.
Terheyden, J. H.
Thiele, S.
Tufail, A.
Varano, M.
Vieweg, L.
Wintergerst, L.
Wolf, A.
Zakaria, N.
Sloan, Kenneth R.
Schmitz-Valckenberg, Steffen
Finger, Robert P.
Holz, Frank G.
Ach, Thomas
,
Funding for this research was provided by:
NIH/NEI (R01EY027948)
Innovative Medicines Initiative 2 Joint Undertaking (116076)
Rheinische Friedrich-Wilhelms-Universität Bonn
Article History
Received: 11 May 2023
Accepted: 23 September 2023
First Online: 13 October 2023
Competing interests
: LvdE: Heidelberg Engineering (R). MM, MV, JH: None. MS: Gerok Research Grant (BONFOR O-137.0030, Faculty of Medicine, University of Bonn, Bonn, Germany), Carl Zeiss MedicTec AG (F), CenterVue (F), Heidelberg Engineering (F). JHT: Heidelberg Engineering (F), Optos (F), Carl Zeiss Meditec (F), CenterVue (F), Novartis (R), Okko (R). KRS: MacRegen Inc (I). SSV: AlphaRET (C), Apellis (C, R), Bayer (F), Bioeq (C), Carl Zeiss MediTec (F), Heidelberg Engineering (F, R), Katairo (C), Kubota Vision (C), Novartis (C, F), Pixium (C), Perceive Therapeutics (C), Roche (C, F), SparingVision (C), STZ GRADE Reading Center (O). RPF: C Alimera, Apellis, Bayer, Böhringer-Ingelheim, Novartis, ODOS, Oxford Innovation, ProGenerika, Roche/Genentech; F Biogen, CentreVue (now Icare), Heidelberg Engineering, Zeiss Meditec. FGH: Acucela (C,F), Allergan (F), Apellis (C, F), Bayer (C, F), Boehringer-Ingelheim (C), Bioeq/Formycon (F,C), CenterVue (F), Ellex (F), Roche/Genentech (C,F), Geuder (C,F), Graybug (C), Gyroscope (C), Heidelberg Engineering (C,F), IvericBio (C, F), Kanghong (C,F), LinBioscience (C), NightStarX (F), Novartis (C,F), Optos (F), Oxurion (C), Pixium Vision (C,F), Oxurion (C), Stealth BioTherapeutics (C), Zeiss (F,C). TA: Roche (C), Novartis (C), Novartis (R), Apellis (C), Bayer (C).